Annals of Nuclear Medicine : Impact Factor & More
eISSN: 1864-6433pISSN: 0914-7187
Share this on:
Key Metrics
CiteScore 
3.6
Impact Factor
< 5
SJR
Q2Radiology, Nuclear Medicine and Imaging
SNIP
0.89
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Annals of Nuclear Medicine
Annals of Nuclear Medicine Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1987 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Annals of Nuclear Medicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Annals of Nuclear Medicine
Lesion-level quantitative Lu-177 PSMA SPECT/CT SUV metrics are associated with interim treatment response in mCRPC: a PET-correlated study.
- 1 Jul 2026
- Annals of nuclear medicine
Correction: Biochemical failure after radical prostatectomy with PSA ≤ 1 ng/mL: prediction of PSMA-positive metastatic disease.
- 1 Jul 2026
- Annals of nuclear medicine
Semi-quantitative tau PET approaches for Braak staging: concordance of CenTauRz and STOC with visual assessment.
- 1 Jul 2026
- Annals of nuclear medicine
The Prognostic Value of 68Ga-PSMA and 18F-FDG PET/CT in Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu-EB-PSMA.
- 1 Jul 2026
- Annals of nuclear medicine
Methodological and clinical considerations on predicting PSMA-positive metastatic disease in early biochemical failure after radical prostatectomy: Comment on Santo et al.
- 1 Jul 2026
- Annals of nuclear medicine
The 68Ga-PSMA-11 PET/CT PRIMARY score for predicting pathological upgrading in ISUP grade group 1 prostate cancer: Methodological considerations and future directions.
- 1 Jul 2026
- Annals of nuclear medicine
Lesion-level quantitative Lu-177 PSMA SPECT/CT SUV metrics are associated with interim treatment response in mCRPC: a PET-correlated study.
- 1 Jul 2026
- Annals of nuclear medicine
Correction: Biochemical failure after radical prostatectomy with PSA ≤ 1 ng/mL: prediction of PSMA-positive metastatic disease.
- 1 Jul 2026
- Annals of nuclear medicine
Semi-quantitative tau PET approaches for Braak staging: concordance of CenTauRz and STOC with visual assessment.
- 1 Jul 2026
- Annals of nuclear medicine
The Prognostic Value of 68Ga-PSMA and 18F-FDG PET/CT in Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu-EB-PSMA.
- 1 Jul 2026
- Annals of nuclear medicine
Methodological and clinical considerations on predicting PSMA-positive metastatic disease in early biochemical failure after radical prostatectomy: Comment on Santo et al.
- 1 Jul 2026
- Annals of nuclear medicine
The 68Ga-PSMA-11 PET/CT PRIMARY score for predicting pathological upgrading in ISUP grade group 1 prostate cancer: Methodological considerations and future directions.
- 1 Jul 2026
- Annals of nuclear medicine
FAQs on Annals of Nuclear Medicine
How long has Annals of Nuclear Medicine been actively publishing? 
What is the publishing frequency of Annals of Nuclear Medicine?
How many articles did Annals of Nuclear Medicine publish last year?
What is the eISSN & pISSN for Annals of Nuclear Medicine?
What is Citescore for Annals of Nuclear Medicine?
What is SNIP score for Annals of Nuclear Medicine?
What is the SJR for Annals of Nuclear Medicine?
Who is the publisher of Annals of Nuclear Medicine?
